HSV-2 Genital Herpes
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing. (NCT00740584) | Starpharma Pty Ltd | 2008-08-01 |
Track HSV-2 Genital Herpes automatically
Every clearance here is in the API, with alerts when new ones post.